Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000891839-21-000140
Filing Date
2021-05-12
Accepted
2021-05-12 16:27:14
Documents
1
Period of Report
2021-05-11

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT edgar.html 4  
1 PRIMARY DOCUMENT edgar.xml 4 9747
  Complete submission text file 0000891839-21-000140.txt   11177
Mailing Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620
Business Address 1895 MOUNT HOPE AVE ROCHESTER NY 14620 585-271-2700
VACCINEX, INC. (Issuer) CIK: 0001205922 (see all company filings)

EIN.: 161603202 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O SURFACE ONCOLOGY, INC. 50 HAMPSHIRE STREET, 8TH FLOOR CAMBRIDGE MA 02139
Business Address
Goater Jeff (Reporting) CIK: 0001656435 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38624 | Film No.: 21915502